Citigroup’s Entero Therapeutics ENTO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1	Closed	-$3K	–	5466
2022 Q2	$3K	Sell	1 -2	-67%	-$6K	﹤0.01%	5017
2022 Q1	$39K	Buy	+3	New	+$39K	﹤0.01%	4132